Cryptobiotix

Technologiepark-Zwijnaarde 82

9052 Gent

BE

Cryptobiotix

Foundation date

27/01/2021

Sector

#Biotechnology - other

Subsector

Therapeutic areas

Preclinical CRO in the gastrointestinal space offering in vitro digestion and ex vivo gut microbiome research services. Cryptobiotix pushes the boundaries of preclinical gastrointestinal research with unparalleled throughput and biorelevance. From early R&D screening to in-depth characterisation of food products and therapeutics, we tailor your project to your research questions and provide you the data to accelerate and de-risk your product development.

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    Monday August 8th 2022

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022

Jobs by Cryptobiotix